Yash Bhatnagar joined Novo Holdings in the San Francisco office as an associate in 2023.
Prior to Novo Holdings, Yash worked on the Investments team at Roivant Sciences, where he analyzed development-stage therapeutic candidates to acquire. Before Roivant, he invested in public healthcare companies at Balyasny Asset Management. Yash began his career in the Healthcare Investment Banking Group at Wells Fargo Securities.
Yash holds a B.S.E. in Biomedical Engineering from Duke University.